Publications
High-dose immunosuppression to prevent death after paraquat self-poisoning - a randomised controlled trial
Gawarammana I, Buckley NA, Mohamed F, Naser K, Jeganathan K, Ariyananada PL, Wunnapuk K, Dobbins TA, Tomenson JA, Wilks MF, Eddleston M, Dawson AH
Clinical Toxicology (Phila), 31 Jul 2018
Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug
Berger B, Bachmann F, Duthaler U, Krähenbühl S, Haschke M
Frontiers in Pharmacology, 24 Jul 2018
Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug
Berger B, Bachmann F, Duthaler U, Krähenbühl S, Haschke M
Frontiers in Pharmacology, 24 Jul 2018
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity
Bal-Price A, Hogberg HT, Crofton KM, Daneshian M, FitzGerald RE, Fritsche E, Heinonen T, Hougaard Bennekou S, Klima S, Piersma AH, Sachana M, Shafer TJ, Terron A, Monnet-Tschudi F, Viviani B, Waldmann T, Westerink RHS, Wilks MF, Witters H, Zurich MG, Leist M
ALTEX, 9 Jul 2018
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity
Bal-Price A, Hogberg HT, Crofton KM, Daneshian M, FitzGerald RE, Fritsche E, Heinonen T, Hougaard Bennekou S, Klima S, Piersma AH, Sachana M, Shafer TJ, Terron A, Monnet-Tschudi F, Viviani B, Waldmann T, Westerink RHS, Wilks MF, Witters H, Zurich MG, Leist M
ALTEX, 9 Jul 2018
Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways
Villeneuve DL, Landesmann B, Allavena P, Ashley N, Bal-Price A, Corsini E, Halappanavar S, Hussell T, Laskin D, Lawrence T, Nikolic-Paterson D, Pallardy M, Paini A, Pieters R, Roth R, Tschudi-Monnet F
Toxicological Sciences, 1 Jui 2018
Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways
Villeneuve DL, Landesmann B, Allavena P, Ashley N, Bal-Price A, Corsini E, Halappanavar S, Hussell T, Laskin D, Lawrence T, Nikolic-Paterson D, Pallardy M, Paini A, Pieters R, Roth R, Tschudi-Monnet F
Toxicological Sciences, 1 Jui 2018
Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells
Grünig D, Duthaler U, Krähenbühl S
Frontiers in Pharmacology, 23 Avr 2018
Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells
Grünig D, Duthaler U, Krähenbühl S
Frontiers in Pharmacology, 23 Avr 2018
Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines
Mingard C, Paech F, Bouitbir J, Krähenbühl S
Journal of Applied Toxicology, 31 Mar 2018